Affiliation:
1. Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
2. The Heart Center, First Hospital of Tsinghua University, Beijing, China
Abstract
Background
This study assessed the role of surgical ablation for atrial fibrillation (
AF
) in decreasing tricuspid regurgitation (
TR
) and right‐sided heart remodeling in patients after mitral valve procedure.
Methods and Results
Between 1994 and 2014, 1568 consecutive patients with
AF
undergoing mitral valve procedure were identified. In 26.0% (n=408), surgical ablation of
AF
was used. Propensity‐score matching (
PSM
) was performed on the basis of 41 known perioperative risk variables. Survival, reoperation, stroke, and moderate‐to‐severe
TR
, as well as echocardiography indices in long‐term follow‐up, were compared in 406 matched patient pairs (ablated and nonablated groups). The nonablated group showed significantly higher risks of death (hazard ratio [
HR
], 1.644; 95%
CI
, 1.081–2.501;
P
=0.020), reoperation (
HR
, 2.644; 95%
CI
, 1.299–5.466;
P
=0.008), and moderate‐to‐severe
TR
(
HR
, 1.436; 95%
CI
, 1.059–1.948;
P
=0.020), associated with a significantly deteriorated cardiac function, progression of
TR
, and right‐sided heart remodeling after 5‐year follow‐up. In a subgroup comparison of ablated patients with sinus rhythm versus
AF
recurrence, a
PSM
analysis was performed at the 5‐year follow‐up. The recurrent group showed significantly higher risks of moderate‐to‐severe
TR
(
HR
, 2.427; 95%
CI
, 1.261–4.671;
P
=0.008).
AF
recurrence was associated with progressive
TR
and significant deterioration in right‐sided heart remodeling.
Conclusions
In a retrospective
PSM
analysis, mitral valve disease with
AF
was associated with
TR
progression as well as right‐sided heart remodeling, which are alleviated by surgical ablation.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine